FDA Clearance Tracker · K262792
Brevera Biopsy System with CorLumina Imaging Technology (BREVDISP09)
Last checked: Nov 20, 2026Latest source record: Aug 12, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Aug 12, 2026
Substantially Equivalent
Time to decision
6 days
Received Aug 6, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K262792
- Device name
- Brevera Biopsy System with CorLumina Imaging Technology (BREVDISP09)
- Applicant
- Hologic, Inc.
- Applicant location
- Malborough, MA
- Received
- Aug 6, 2026
- Decided
- Aug 12, 2026
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device type
- Instrument, Biopsy (KNW)
- Device class
- Class II
- Regulation
- 21 CFR 876.1075
- Specialty
- GI, Urology & Nephrology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code KNW. The earliest in FDA's data is K760868, decided Nov 1, 1976.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K262792
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Hologic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- I-View®510(k)
K254090 · Decided Sep 2, 2026 · 257 days after receipt
Device type: Full Field Digital, System, X-Ray, Mammographic (MUE) · Radiology & Imaging
K253634 · Decided Jun 17, 2026 · 210 days after receipt
Device type: Electrosurgical, Cutting & Coagulation & Accessories (GEI) · General & Plastic Surgery
K251993 · Decided Sep 25, 2025 · 90 days after receipt
Device type: Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay System (PCH) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.